$2.99
0.02[0.67%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$2.98
-0.0100[-0.33%]
| Open2.970 | Close2.990 |
| Vol / Avg.25.390K / 973.020K | Mkt Cap249.759M |
| Day Range2.960 - 3.160 | 52 Wk Range1.680 - 3.830 |
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
AC Immune Stock (NASDAQ:ACIU), Key Statistics
AC Immune Stock (NASDAQ: ACIU) analysis, key statistics.
Valuation Measures
Enterprise Value
148.1M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
56.77
Price / Book (mrq)
1.6
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-29.95%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.85
Tangible Book value per share
1.18
Total Liabilities (Quarterly)
16.9M
Total Assets
156.2M
Total Liabilities
16.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -